Miller Dental Lab LLC ,

Info
Special Offers
Map & Directions
  • No Records Found

    Sorry, no records were found. Please adjust your search criteria and try again.

    Google Map Not Loaded

    Sorry, unable to load Google Maps API.

  • 24/7 Dental – Emergency Dental Care

  • 12th Street Dental Office

  • 19th Street Dental

  • 1st Family Dental of Elgin

  • 4th Avenue Family Dentistry

  • 20 Finch Dental

  • Aurora Bay Area Prices – DOXORUBICIN HCL 2 MG/ML IV SOLN (SPLIT X 2) is $9.11

    At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10002800, regarding DOXORUBICIN HCL 2 MG/ML IV SOLN (SPLIT X 2), which is classified under revenue code 250 and associated with CPT code J9000, the designated fee stands at $9.11. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.

  • Aurora Sheboygan Prices – XR UROGRAPHY ANTEGRADE S&I is $1,070.00

    At Aurora Medical Center Sheboygan, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10000493, regarding XR UROGRAPHY ANTEGRADE S&I, which is classified under revenue code 320 and associated with CPT code 74425, the designated fee stands at $1,070.00. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.

  • Aurora Bay Area Prices – PENTOBARBITAL is $175

    At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10000800, regarding PENTOBARBITAL, which is classified under revenue code 301 and associated with CPT code 80345, the designated fee stands at $175. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.

  • Can a 3-Year-Old With Severe Sickle Cell Get Casgevy Now?

    FDA’s July 1, 2026 expanded Casgevy (exa-cel) use for children as young as age 2 with severe sickle cell disease (SCD) and recurrent vaso-occlusive crises (VOCs). “Approved” doesn’t automatically mean every 3-year-old can receive it right away—eligibility details and specialized-center capacity for intensive monitoring matter.